Table 5.
Exosomes and Their Components as Biomarkers for Cervical Cancer.
| Biomarker | Trend | Type | Source | Recipient cells | Functions | Application | Ref |
|---|---|---|---|---|---|---|---|
| let-7d-3p, miR-30d-5p | Decrease | miRNA | Plasma | — | Biomarker | Early detection in plasma | 104 |
| miR-146a-5p, miR-151a-3p, miR-2110, miR-21-5p | Increase | miRNA | Plasma | — | Biomarker | Early detection in plasma | 105 |
| miR-125a-5p | Decrease | miRNA | Plasma | — | Biomarker | Early detection in plasma | 106 |
| miR-21, miR-146a | Increase | miRNA | Cervicovaginal lavage | — | Biomarker | Early detection in cervicovaginal lavage | 107 |
| HOTAIR, MALAT1 | Increase | lncRNA | Cervicovaginal lavage | — | Biomarker | Early detection in cervicovaginal lavage | 108 |
| MEG3 | Decrease | lncRNA | Cervicovaginal lavage | — | Biomarker | Early detection in cervicovaginal lavage | 108 |
| DLX6-AS1 | Increase | lncRNA | Serum | — | Biomarker | Prognosis in serum | 109 |
| lncRNA-EXOC7 | Increase | lncRNA | Serum | — | Biomarker | Prognosis in serum | 110 |